D-dimer as a potential blood biomarker for disease activity and treatment response in chronic urticaria: a focused review

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

D-dimer as a potential blood biomarker for disease activity and treatment response in chronic urticaria : a focused review. / Ghazanfar, Misbah Noshela; Thomsen, Simon Francis.

I: European Journal of Dermatology, Bind 28, Nr. 6, 2018, s. 731-735.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

Ghazanfar, MN & Thomsen, SF 2018, 'D-dimer as a potential blood biomarker for disease activity and treatment response in chronic urticaria: a focused review', European Journal of Dermatology, bind 28, nr. 6, s. 731-735. https://doi.org/10.1684/ejd.2018.3443

APA

Ghazanfar, M. N., & Thomsen, S. F. (2018). D-dimer as a potential blood biomarker for disease activity and treatment response in chronic urticaria: a focused review. European Journal of Dermatology, 28(6), 731-735. https://doi.org/10.1684/ejd.2018.3443

Vancouver

Ghazanfar MN, Thomsen SF. D-dimer as a potential blood biomarker for disease activity and treatment response in chronic urticaria: a focused review. European Journal of Dermatology. 2018;28(6):731-735. https://doi.org/10.1684/ejd.2018.3443

Author

Ghazanfar, Misbah Noshela ; Thomsen, Simon Francis. / D-dimer as a potential blood biomarker for disease activity and treatment response in chronic urticaria : a focused review. I: European Journal of Dermatology. 2018 ; Bind 28, Nr. 6. s. 731-735.

Bibtex

@article{13169cd3453349fb9a56ae62f97d4df4,
title = "D-dimer as a potential blood biomarker for disease activity and treatment response in chronic urticaria: a focused review",
abstract = "Chronic urticaria is an itchy skin disease, which is treated with antihistamines; however, a large group of patients are unresponsive to antihistamines alone and are thus treated with omalizumab, although a small fraction of these patients have particularly recalcitrant disease. Currently, there are no reliable biomarkers available to assess disease activity/severity and treatment response in chronic urticaria patients. However, it has been reported that high levels of d-dimer are observed during disease activity and are significantly reduced during periods of remission. We present a focused overview of studies investigating plasma d-dimer level as a biomarker for disease activity and treatment response in patients with chronic urticaria.",
keywords = "chronic urticaria, D-dimer, biomarker, disease activity, treatment response",
author = "Ghazanfar, {Misbah Noshela} and Thomsen, {Simon Francis}",
year = "2018",
doi = "10.1684/ejd.2018.3443",
language = "English",
volume = "28",
pages = "731--735",
journal = "European Journal of Dermatology",
issn = "1167-1122",
publisher = "JohnLibbey Eurotext",
number = "6",

}

RIS

TY - JOUR

T1 - D-dimer as a potential blood biomarker for disease activity and treatment response in chronic urticaria

T2 - a focused review

AU - Ghazanfar, Misbah Noshela

AU - Thomsen, Simon Francis

PY - 2018

Y1 - 2018

N2 - Chronic urticaria is an itchy skin disease, which is treated with antihistamines; however, a large group of patients are unresponsive to antihistamines alone and are thus treated with omalizumab, although a small fraction of these patients have particularly recalcitrant disease. Currently, there are no reliable biomarkers available to assess disease activity/severity and treatment response in chronic urticaria patients. However, it has been reported that high levels of d-dimer are observed during disease activity and are significantly reduced during periods of remission. We present a focused overview of studies investigating plasma d-dimer level as a biomarker for disease activity and treatment response in patients with chronic urticaria.

AB - Chronic urticaria is an itchy skin disease, which is treated with antihistamines; however, a large group of patients are unresponsive to antihistamines alone and are thus treated with omalizumab, although a small fraction of these patients have particularly recalcitrant disease. Currently, there are no reliable biomarkers available to assess disease activity/severity and treatment response in chronic urticaria patients. However, it has been reported that high levels of d-dimer are observed during disease activity and are significantly reduced during periods of remission. We present a focused overview of studies investigating plasma d-dimer level as a biomarker for disease activity and treatment response in patients with chronic urticaria.

KW - chronic urticaria

KW - D-dimer

KW - biomarker

KW - disease activity

KW - treatment response

U2 - 10.1684/ejd.2018.3443

DO - 10.1684/ejd.2018.3443

M3 - Review

C2 - 30530404

VL - 28

SP - 731

EP - 735

JO - European Journal of Dermatology

JF - European Journal of Dermatology

SN - 1167-1122

IS - 6

ER -

ID: 218088240